Search

everythinglearnresearchcommunity

for

Search:↓

The guidelines help doctors manage skin problems from certain cancer treatments to improve patients' lives.

A compound from Calophyllum inophyllum L. leaf may help treat non-small cell lung cancer.

A cancer patient's eyelashes grew excessively without other common side effects after taking the cancer drug erlotinib.

Combining ficlatuzumab and gefitinib can cause severe scarring hair loss.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

An 84-year-old man developed a rare scalp condition from a cancer drug but continued treatment as it was otherwise well tolerated.

Skin problems like acne, dry skin, and nail and hair changes are common in patients taking EGFR inhibitors.

The document provides advice on how to recognize and treat skin-related side effects of cancer drugs known as EGFR inhibitors.

Some lung cancer patients treated with EGFR inhibitors may develop a hair loss condition similar to folliculitis decalvans.

EGFR inhibitors can cause various skin issues during cancer treatment, and managing these is important for patient care.

BAY 43-9006 helps control kidney cancer growth but doesn't significantly increase overall survival.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

New chemotherapy drugs cause skin side effects, but treatments like minocycline and tetracycline can help reduce them.

A protein called IL-36γ causes skin side effects from certain cancer treatments when combined with a common skin bacteria.

Cancer treatments can cause skin-related side effects that may affect patient quality of life and require changes in treatment.

Skin reactions from cancer treatments might predict how well the treatments work.

Afatinib often causes skin problems that need proactive management.

Targeted cancer therapies often cause serious skin problems that need careful management.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

Adverse events in lung cancer treatments increase fear, anxiety, and depression, with newer therapies causing fewer side effects.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Gefitinib can cause skin problems, diarrhea, and nausea, but rarely causes severe lung disease or hair loss.

Spironolactone may make some cancer treatments more effective by blocking a protein that helps cancer cells survive.

A cancer patient developed a type of hair loss after starting a cancer drug called vandetanib.

Chemotherapy can cause skin side effects that affect patients' lives, but they can be managed to avoid interrupting cancer treatment.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.